Huntsman (HUN) Gains on Downstream Expansion, Acquisitions

The company's shares are down 8.6% over a year, compared with a 6.1% decline of its industry. Huntsman, a Zacks Rank #3 (Hold) stock, remains focused on growing its downstream specialty and formulation businesses and is shifting its MDI (methylene diphenyl diisocyanate) business from components to differentiated systems that typically have higher margins and lower volatility. Huntsman should also gain from significant synergies of acquisitions. Its strong liquidity and balance sheet leverage give it adequat ...